Raymondd T. Krediet

Raymondd T. Krediet's AcademicInfluence.com Rankings

Raymondd T. Krediet

Philosophy

#6924

World Rank

#10050

Historical Rank

Logic

#4009

World Rank

#5250

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Raymondd T. Krediet's Degrees

Bachelors Biology University of Amsterdam
Masters Biomedical Sciences University of Amsterdam
PhD Medical Sciences University of Groningen

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Raymondd T. Krediet Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Raymondd T. Krediet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. (2003) (567)
Vascular and Interstitial Changes in the Peritoneum of Capd Patients with Peritoneal Sclerosis (1999) (355)
Pathophysiology of Peritoneal Membrane Failure (2000) (240)
Damage of the endothelial glycocalyx in dialysis patients. (2012) (233)
Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis (2000) (215)
The peritoneal membrane in chronic peritoneal dialysis. (1999) (200)
The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. (1995) (199)
Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. (1996) (198)
Peritoneal transport characteristics with glucose polymer based dialysate. (1996) (185)
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. (2001) (179)
Guideline on Targets for Solute and Fluid Removal in Adult Patients on Chronic Peritoneal Dialysis (2006) (170)
Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. (2000) (169)
Growth factor VEGF and TGF-?1 in peritoneal dialysis (1999) (163)
Peritoneal Sclerosis in Chronic Peritoneal Dialysis Patients: Analysis of Clinical Presentation, Risk Factors, and Peritoneal Transport Kinetics (1997) (161)
Predicting mortality in intensive care patients with acute renal failure treated with dialysis. (1997) (154)
Acute interstitial nephritis: a clinical and morphological study in 27 patients. (1990) (146)
Analysis of Ultrafiltration Failure in Peritoneal Dialysis Patients by Means of Standard Peritoneal Permeability Analysis (1997) (142)
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. (1994) (140)
Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients (1987) (139)
A prospective study of peritoneal transport in CAPD patients. (1994) (139)
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. (1994) (139)
Longitudinal follow-up of CA125 in peritoneal effluent. (1997) (135)
Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. (1993) (132)
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. (1995) (132)
Cardiovascular risk in the peritoneal dialysis patient (2010) (128)
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. (2002) (128)
Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. (2011) (126)
Circadian rhythm of glomerular filtration rate in normal individuals. (1989) (123)
Peritoneal Function and Assessment of Reference Values Using a 3.86% Glucose Solution (2003) (119)
Peritoneal physiology-transport of solutes (1994) (119)
Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. (1986) (118)
Dialysate Cancer Antigen 125 Concentration as Marker of Peritoneal Membrane Status in Patients Treated with Chronic Peritoneal Dialysis (2001) (116)
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. (1993) (114)
European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. (2005) (110)
Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. (2001) (110)
Peritoneal changes in patients on long-term peritoneal dialysis (2013) (108)
Circadian rhythm of glomerular filtration rate in normal individuals (1989) (106)
Quantification of free water transport in peritoneal dialysis. (2004) (105)
Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. (1993) (105)
Growth factors VEGF and TGF-beta1 in peritoneal dialysis. (1999) (104)
Analysis of the Prevalence and Causes of Ultrafiltration Failure during Long-Term Peritoneal Dialysis: A Cross-Sectional Study (2004) (101)
Neoangiogenesis in the Peritoneal Membrane (2000) (101)
Demonstration of Aquaporin-Chip in Peritoneal Tissue of Uremic and Capd Patients (1996) (100)
Fluid and solute transport in CAPD patients using ultralow sodium dialysate. (1994) (100)
Does Impaired Transcellular Water Transport Contribute to Net Ultrafiltration Failure during CAPD? (1995) (98)
Encapsulating peritoneal sclerosis: the state of affairs (2011) (97)
EARLY DIAGNOSTIC MARKERS FOR ENCAPSULATING PERITONEAL SCLEROSIS: A CASE-CONTROL STUDY (2010) (90)
Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. (1991) (89)
Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. (1991) (89)
Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. (1986) (88)
Computed Tomographic Findings Characteristic for Encapsulating Peritoneal Sclerosis: A Case-Control Study (2009) (87)
Nolph and Gokal's Textbook of Peritoneal Dialysis (2009) (86)
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. (2006) (84)
Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. (2010) (83)
Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. (1993) (83)
Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges. (1988) (78)
European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. (2005) (77)
Circadian rhythm of proteinuria: consequences of the use of urinary protein:creatinine ratios. (1989) (75)
Impact of ACE Inhibitors and AII Receptor Blockers on Peritoneal Membrane Transport Characteristics in Long-Term Peritoneal Dialysis Patients (2007) (75)
Discrepancy between circadian rhythms of inulin and creatinine clearance. (1992) (71)
The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. (2011) (71)
The peritoneal transport of serum proteins and neutral dextran in CAPD patients. (1989) (70)
The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. (1989) (70)
A Comparison between 1.36% and 3.86% Glucose Dialysis Solution for the Assessment of Peritoneal Membrane Function (2000) (70)
Dietary Protein Requirements and Dialysate Protein Losses in Chronic Peritoneal Dialysis Patients (2007) (69)
Peritoneal Transport Characteristics of Water, Low-Molecular Weight Solutes and Proteins during Long Term Continuous Ambulatory Peritoneal Dialysis (1986) (68)
The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. (1997) (66)
Dialysate Markers of Peritoneal Tissue during Peritonitis and in Stable CAPD (1995) (66)
European best practice guidelines for peritoneal dialysis - Preface; European Best Practice Guideline (2005) (66)
Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. (1993) (65)
Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. (1996) (64)
Determinants of Peritoneal Solute Transport Rates in Newly Started Nondiabetic Peritoneal Dialysis Patients (2004) (64)
Day-To-Day Variability of Protein Transport Used as a Method for Analyzing Peritoneal Permeability in CAPD (1991) (63)
Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. (1992) (63)
32 Years’ Experience of Peritoneal Dialysis-Related Peritonitis in a University Hospital (2014) (62)
Cyclosporin A Induces Peritoneal Fibrosis and Angiogenesis during Chronic Peritoneal Exposure to a Glucose-Based, Lactate-Buffered Dialysis Solution in the Rat (2007) (62)
The physiology of peritoneal solute transport and ultrafiltration (2000) (61)
Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. (2001) (61)
Correction of sodium sieving for diffusion from the circulation. (1999) (60)
The Mesothelial Cells in CAPD Effluent and Their Relation to Peritonitis Incidence (1991) (59)
Evaluation of Peritoneal Transport and Membrane Status in Peritoneal Dialysis: Focus on Incident Fast Transporters (2007) (59)
Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. (1994) (58)
Acute Effects of High-Dose Furosemide on Residual Renal Function in CAPD Patients (2003) (58)
A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption. (1991) (58)
Formula-Derived Prediction of the Glomerular Filtration Rate from Plasma Creatinine Concentration (2002) (57)
The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. (2005) (56)
Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. (1998) (56)
The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis. (1987) (55)
A circadian rhythm of proteinuria in patients with a nephrotic syndrome. (1985) (54)
Deficiencies of vitamins in CAPD patients: the effect of supplementation. (1988) (53)
Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. (2003) (52)
Ultrafiltration Failure in Continuous Ambulatory Peritoneal Dialysis (1993) (51)
Icodextrin'S Effects on Peritoneal Transport (1997) (50)
Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. (2010) (48)
Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. (1995) (48)
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. (1994) (47)
European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. (2005) (47)
Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients. (1987) (46)
The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease. (2010) (46)
Dialysate CA125 in stable CAPD patients: no relation with transport parameters. (1995) (46)
Current status and practical use of effluent biomarkers in peritoneal dialysis patients. (2013) (45)
Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. (1996) (45)
Analysis of Inflammatory Mediators and Peritoneal Permeability to Macromolecules Shortly before the Onset of Overt Peritonitis in Patients Treated with CAPD (1995) (43)
30 Years of Peritoneal Dialysis Development: The past and the Future (2007) (43)
Icodextrin Degradation Products in Spent Dialysate of CAPD Patients and the Rat, and its Relation with Dialysate Osmolality (2001) (43)
Cimetidine improves prediction of the glomerular filtration rate by the cockcroft-gault formula in renal transplant recipients (2002) (43)
Quantification of Free Water Transport during the Peritoneal Equilibration Test (2009) (42)
The Disappearance of Macromolecules from the Peritoneal Cavity during Continuous Ambulatory Peritoneal Dialysis (CAPD) is Not Dependent on Molecular Size (1990) (42)
Impact of Surface Area and Permeability on Solute Clearances (1994) (42)
Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? (1996) (41)
Augmenting solute clearance in peritoneal dialysis. (1998) (40)
Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. (1994) (39)
Antigen‐presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis (1993) (39)
The Difference in Causes of Early and Late Ultrafiltration Failure in Peritoneal Dialysis (2005) (38)
Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? (1998) (38)
Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis. (1997) (38)
Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci (1995) (37)
European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. (2005) (37)
Intraperitoneal Interleukin-8 and Neutrophil Influx in the Initial Phase of a Capd Peritonitis (1996) (37)
Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. (1998) (36)
Peritoneal Transport Characteristics with Glycerol-Based Dialysate in Peritoneal Dialysis (2000) (36)
Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis. (1989) (36)
How to preserve residual renal function in patients with chronic kidney disease and on dialysis? (2006) (36)
CAPD peritonitis: a prospective randomized trial of oral versus intraperitoneal treatment with cephradine. (1986) (36)
Analysis of Non Enzymatic Glycosylation In Vivo: Impact of Different Dialysis Solutions (1999) (35)
Immunoglobulins in chronic renal failure of childhood: effects of dialysis modalities. (2000) (35)
Fluid loss does not explain coagulation activation during air travel (2008) (35)
The effect of glucose polymers on water removal and protein clearances during CAPD. (1993) (35)
Indices of Peritoneal Permeability and Surface Area (1993) (34)
Nitrate in stable CAPD patients and during peritonitis. (1995) (34)
Does Lymphatic Absorption Change with the Duration of Peritoneal Dialysis? (2004) (34)
Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. (1996) (34)
A Pyruvate-Buffered Dialysis Fluid Induces Less Peritoneal Angiogenesis and Fibrosis than a Conventional Solution (2008) (34)
Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. (1994) (34)
The First Peritonitis Episode Alters the Natural Course of Peritoneal Membrane Characteristics in Peritoneal Dialysis Patients (2015) (34)
Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of the creatinine assay. (1999) (33)
Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells (1996) (32)
Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. (2012) (32)
Individual characterization of the peritoneal restriction barrier to macromolecules. (1991) (31)
Standard peritoneal permeability analysis in children. (2000) (31)
Indirect measurement of lymphatic absorption in CAPD patients is not influenced by trapping. (1992) (31)
Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients? (2013) (31)
Leakage of dialysate across the diaphragm: an important complication of continuous ambulatory peritoneal dialysis. (1986) (31)
Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport. (2004) (31)
Use of icodextrin in high transport ultrafiltration failure. (2002) (30)
Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis (2018) (30)
Circadian rhythms and the kidney. A review. (1985) (30)
Expression of Cancer Antigen 125 by Peritoneal Mesothelial Cells is Not Influenced by Duration of Peritoneal Dialysis (2001) (29)
Changes in Weight and Lipid Concentrations during CAPD Treatment (1988) (29)
Longitudinal Analysis of Peritoneal Fluid Transport and Its Determinants in a Cohort of Incident Peritoneal Dialysis Patients (2014) (29)
The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis. (2000) (29)
Prognostic factors for peritonitis outcome. (2012) (29)
INDUCTION OF CHRONIC KIDNEY FAILURE IN A LONG-TERM PERITONEAL EXPOSURE MODEL IN THE RAT: EFFECTS ON FUNCTIONAL AND STRUCTURAL PERITONEAL ALTERATIONS (2010) (29)
Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. (1995) (28)
Water Channels in the Peritoneum (1996) (28)
The Effective Lymphatic Absorption Rate is an Accurate and Useful Concept in the Physiology of Peritoneal Dialysis (2004) (28)
Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis. (2015) (28)
Residual volume measurements in CAPD patients with exogenous and endogenous solutes. (1992) (27)
Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis. (1997) (27)
Fluid and Solute Transport across the Peritoneum during Continuous Ambulatory Peritoneal Dialysis (CAPD) (1989) (26)
Sodium Balance in Automated Peritoneal Dialysis (2000) (26)
Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients. (2011) (26)
Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. (2010) (26)
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD? (2008) (26)
Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD. (1997) (25)
Glomerulopathy as a paraneoplastic phenomenon. (1989) (25)
The Physiology of Peritoneal Solute, Water, and Lymphatic Transport (2009) (25)
Dialysate leucocytosis in CAPD patients without clinical infection. (1988) (25)
Indirect Measurement of Lymphatic Absorption with Inulin in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients (1990) (25)
Modeling a hydropic recipient twin in twin-twin transfusion syndrome. (2005) (25)
European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. (2005) (24)
The value of osmotic conductance and free water transport in the prediction of encapsulating peritoneal sclerosis. (2014) (24)
Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy. (1991) (24)
Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function (2009) (24)
Measurement of intraperitoneal fluid kinetics in CAPD patients by means of autologous haemoglobin. (1988) (24)
Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD. (2004) (24)
Effect of Fluid Supplementation and Modality on Peritoneal Permeability Characteristics in a Rat Peritoneal Dialysis Model (2001) (23)
Acute Effects of Peritoneal Dialysis on Hemodynamics (2001) (23)
Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis. (2007) (23)
Acute pancreatitis during CAPD in The Netherlands. (1993) (22)
Is the decline of renal function different before and after the start of dialysis? (2013) (22)
Impaired Initial Cell Reaction in Capd-Related Peritonitis (1996) (22)
The Effect of Various Dialysis Solutions on Peritoneal Membrane Viability (1999) (22)
A solutions portfolio approach in peritoneal dialysis. (2003) (22)
Peritoneal Membrane Failure in Peritoneal Dialysis Patients (2002) (22)
The Natural Time Course of Membrane Alterations During Peritoneal Dialysis Is Partly Altered by Peritonitis (2016) (21)
Fluid kinetics in CAPD patients during dialysis with a bicarbonate-based hypoosmolar solution. (1996) (21)
Preservation of peritoneal membrane function. (1996) (21)
The Mutual Relationship Between Peritonitis and Peritoneal Transport (2016) (21)
Cancer Antigen 1251S Locally Produced in the Peritoneal Cavity during Continuous Ambulatory Peritoneal Dialysis (1994) (21)
The Standard Peritoneal Permeability Analysis in the Rabbit: A Longitudinal Model for Peritoneal Dialysis (1999) (21)
Mannose-binding lectin (MBL2) and ficolin-2 (FCN2) polymorphisms in patients on peritoneal dialysis with staphylococcal peritonitis. (2011) (20)
Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. (2004) (20)
Measurement of peritoneal fluid handling in children on continuous ambulatory peritoneal dialysis using dextran 70. (1995) (20)
Does the Biocompatibility of the Peritoneal Dialysis Solution Matter in Assessment of Peritoneal Function? (2007) (20)
THE EFFECTS OF A DIALYSIS SOLUTION WITH A COMBINATION OF GLYCEROL/AMINO ACIDS/DEXTROSE ON THE PERITONEAL MEMBRANE IN CHRONIC RENAL FAILURE (2010) (20)
Peritoneal transport of macromolecules in patients on CAPD. (1991) (20)
The cellular contribution to effluent potassium and its relation to free water transport during peritoneal dialysis. (2007) (20)
Fluid absorption in the peritoneum--it is less simple than you thought. (1994) (19)
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. (2001) (19)
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae. (1998) (19)
Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. (2000) (19)
Imaging in encapsulating peritoneal sclerosis (2011) (19)
Assessment of Peritoneal Fibrosis by Conventional Light Microscopy and Hydroxyproline Measurements (2004) (19)
AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. (2021) (19)
Impact of Different Dialysis Solutions on Solute and Water Transport (1997) (18)
Prevention and Treatment of Peritoneal Dialysis Mebrane Failure (1998) (18)
Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients? (2016) (18)
Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children. (2004) (18)
Characteristics of Peripheral and Peritoneal White Blood Cells in Children with Chronic Renal Failure, Dialyzed or Not (2000) (18)
Use of Angiotensin II Inhibitors in Patients That Develop Encapsulating Peritoneal Sclerosis (2010) (18)
Intraperitoneal Administration of Recombinant Human Erythropoietin (1992) (17)
Biological markers in the peritoneal dialysate effluent: are they useful. (2009) (17)
Serum interleukin-6 in continuous ambulatory peritoneal dialysis in patients. (1993) (17)
Advances in Peritoneal Dialysis: Towards Improved Efficacy and Safety (1998) (17)
Protein Clearance and Icodextrin (1994) (17)
Effect of intraperitoneal administration of two different batches of albumin solutions on peritoneal solute transport in CAPD patients. (1991) (16)
Modeling of Icodextrin in PD Adequest® 2.0 (2006) (16)
Peritoneal physiology--impact on solute and fluid clearance. (2000) (16)
IgG glycation and function during continuous ambulatory peritoneal dialysis. (1997) (16)
Free water transport, small pore transport and the osmotic pressure gradient. (2008) (16)
Circadian rhythm of urinary beta 2 microglobulin excretion in patients with a nephrotic syndrome. (1987) (15)
Inflammatory changes in vivo during CAPD: what can the effluent tell us? (1996) (15)
European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. (2005) (15)
Alpha-2-Macroglobulin and Albumin are Useful Serum Proteins to Detect Subclinical Peritonitis in the Rat (2006) (15)
Clearance ratios of amylase isoenzymes and IgG subclasses: do they reflect glomerular charge selectivity? (1997) (15)
Encapsulating Peritoneal Sclerosis in a Peritoneal Dialysis Patient Using Biocompatible Fluids Only: Is Alport Syndrome a Risk Factor? (2010) (15)
Igg Subclasses in Capd Patients (1996) (14)
Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits. (1999) (14)
Experimental Study on Long-Term Exposure to a Biocompatible, Hypertonic, Pyruvate-Buffered Dialysis Solution (2008) (14)
European best practice guidelines for peritoneal dialysis. 9 PD and transplantation. (2005) (14)
Viral peritonitis in a continuous ambulatory peritoneal dialysis patient. (1986) (14)
Dry body weight: water and sodium removal targets in PD. (2006) (14)
Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states. (1987) (14)
Free water transport in patients starting with peritoneal dialysis: a comparison between diabetic and non diabetic patients. (2004) (13)
Practical methods for assessing dialysis efficiency during peritoneal dialysis. (1994) (13)
Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine. (1995) (13)
Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose. (2021) (13)
Advances in peritoneal dialysis. (2007) (13)
Evaluation of Short-Chain Polypeptides as An Osmotic Agent in Continuous Ambulatory Peritoneal Dialysis Patients (1994) (13)
Bilateral kidney rupture with severe retroperitoneal bleeding in polyarteritis nodosa. (1989) (13)
European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems. (2005) (13)
Adherence of Staphylococci to plastic, mesothelial cells and mesothelial extracellular matrix. (1992) (13)
Prevention and treatment of peritoneal dialysis membrane failure. (1998) (12)
Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment. (1981) (12)
The truth on current peritoneal dialysis: state of the art. (2017) (12)
Peritoneal Membrane Evaluation in Routine Clinical Practice (2008) (12)
Is the Systemic Microvascular Endothelial Glycocalyx in Peritoneal Dialysis Patients Related to Peritoneal Transport? (2014) (11)
Effects of Inhibition of the Polyol Pathway during Chronic Peritoneal Exposure to a Dialysis Solution (2005) (11)
Diffusion correction of sodium sieving applicable in a peritoneal equilibration test. (2003) (11)
Effects of renal failure on complement C3d levels. (1991) (11)
Evaluation of peritoneal membrane integrity. (1997) (11)
Effects of icodextrin on the peritoneal membrane. (2010) (11)
Peritoneal dialysis: from bench to bedside (2013) (10)
[Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients]. (2006) (10)
Sodium Sieving in Children (2005) (10)
Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. (1999) (10)
Markers of Peritoneal Membrane Status (1996) (10)
What Can We Do to Preserve the Peritoneum? (2003) (10)
Amphotericin B, mercury chloride and peritoneal transport in rabbits. (2001) (10)
Ultrafiltration failure in peritoneal dialysis. Causes and clinical consequences. (2005) (10)
Elevated 24-hour blood pressure in peritoneal dialysis patients with ultrafiltration failure. (1998) (9)
Diagnosis and treatment of HIV-associated nephropathy. (2001) (9)
Experimental Peritoneal Sclerosis Models Should Not Be Based on Chlorhexidine Gluconate Anymore (2010) (9)
Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both? (2019) (9)
IGG and complement receptor expression on peripheral white blood cells in uraemic children. (2004) (9)
Measurement of Peritoneal Fluid Handling in Children on Continuous Ambulatory Peritoneal Dialysis Using Autologous Hemoglobin (1994) (9)
Can Plasma Hyaluronan and Hyaluronidase Be Used As Markers of the Endothelial Glycocalyx State in Patients with Kidney Disease? (2015) (9)
Dextran Antibodies in Peritoneal Dialysis Patients Treated with Icodextrin (2002) (9)
A 39-year-old man with loss of ultrafiltration. (1994) (8)
Use of the disappearance rate for the estimation of lymphatic absorption during CAPD. (1992) (8)
Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients. (1998) (8)
Effluent Hydroxyproline in Experimental Peritoneal Dialysis (2007) (8)
Surgical problems in continuous ambulatory peritoneal dialysis (CAPD). (1982) (8)
Are peritoneal calcifications in long-term peritoneal dialysis related to aortic calcifications and disturbances in mineral metabolism? (2011) (8)
Peritoneal anatomy and physiology during peritoneal dialysis (1996) (8)
The Use of Peptides in Peritoneal Dialysis Fluids (1994) (8)
Dialysis treatment in patients with rheumatoid arthritis. (1995) (8)
Peritoneal vasculopathy in the pathophysiology of long-term ultrafiltration failure: A hypothesis based on clinical observations . (2019) (7)
Effects of tracer, volume, osmolarity and infection on fluid kinetics during CAPD. (1992) (7)
Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. (2019) (7)
ANTIFUNGAL TREATMENT OF CANDIDA PERITONITIS IN CAPD PATIENTS (1987) (7)
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis. (2003) (7)
Production of IL-1 beta and TNF-alpha by peritoneal macrophages depends on the bacterial species and the inoculum. (1997) (7)
Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis. (2000) (7)
The rise and fall of the K(t)/V concept in CAPD. (2002) (7)
Encapsulating peritoneal sclerosis in patients on peritoneal dialysis. (2008) (7)
Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes. (2019) (7)
Accuracy of Erythropoietin Determination in Dialysate of CAPD Patients (1990) (7)
The effect of amphotericin B on fluid kinetics and solute transport in CAPD patients. (1993) (6)
Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis. (1991) (6)
Acute Interstitial Nephritis during Continuous Intravenous Administration of Low-Dose lnterleukin-2 (1992) (6)
Similarities in functional state of the kidney in patients treated with CAPD and hemodialysis. (1996) (6)
Free water transport in children on peritoneal dialysis is higher with more biocompatible dialysis solutions, higher with older age and declines with time. (2012) (6)
Peritoneal dialysis membrane evaluation in clinical practice. (2012) (6)
Overhydration May Be the Missing Link between Peritoneal Protein Clearance and Mortality (2021) (6)
Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer (2005) (5)
Peritoneal dialysis and cardiovascular disease. (2012) (5)
[Experiences with acute peritoneal dialysis in adults]. (1984) (5)
Clinical significance and detection of individual differences and changes in transperitoneal transport. (1994) (5)
Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis. (1991) (5)
Lymphangiogenesis and Lymphatic Absorption Are Related and Increased in Chronic Kidney Failure, Independent of Exposure to Dialysis Solutions. (2015) (5)
The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients (2016) (5)
Do low GDP neutral pH solutions prevent or retard peritoneal membrane alterations in long-term peritoneal dialysis? (2021) (5)
Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility (2020) (5)
Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production. (1993) (5)
The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients (2008) (5)
Renal involvement in Behçet's syndrome. Report of a case and a review of the literature. (1989) (5)
Osmotic agents in automated peritoneal dialysis solutions. (1999) (5)
The Initial Decrease in Effective Peritoneal Surface Area is Not Caused by an Increase in Hematocrit (1993) (5)
Similarities and Differences between the Effects of Amino Acids and Nitroprusside on Peritoneal Permeability during CAPD (1998) (5)
A two-hit approach in the development of an experimental peritoneal sclerosis model. (2012) (5)
Fluid transport with time on peritoneal dialysis: the contribution of free water transport and solute coupled water transport. (2009) (4)
Enalapril-associated anemia in a patient with IgA nephropathy and hypertension. (1992) (4)
[Relation between clinical condition and quality of life in patients on hemodialysis, a clinimetric study]. (1991) (4)
New Peritoneal Dialysis Solutions and Solutions on the Horizon (2009) (4)
European best practice guidelines for peritoneal dialysis. 1 General guidelines. (2005) (4)
Karl D. Nolph State of the Art Lecture: Feasible and Future Options for Salvation of the Peritoneal Membrane (2009) (4)
Does Residual Volume after Drainage Matter in Peritoneal Dialysis Treatment? (2004) (4)
Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis (2008) (4)
New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum (2016) (4)
Clinical aspects of peritoneal permeability. (1985) (4)
Circadian rhythm of proteinuria: relationship with molecular weight of proteins and influence of prostaglandin inhibition. (1988) (4)
Biocompatible Peritoneal Dialysis Solutions do not Induce Less Net Ultrafiltration than Conventional Solutions (2008) (4)
European best practice guidelines: adequacy in peritoneal dialysis. (2003) (4)
Sodium content in automated peritoneal dialysis solutions. (1999) (4)
Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients (2022) (4)
Physiology of High/Fast Transporters (2009) (4)
Lack of correlation between baseline peritoneal membrane status and pre-dialytic characteristics. (2010) (4)
New Insights into the Physiology of Peritoneal Fluid Transport (2008) (4)
Leakage of Dialysate across the Diaphragm (1990) (3)
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world. (2010) (3)
Demonstration of Aquaporin-chip in Peritoneal Tissue of Uremic and CAPD Patients (1996) (3)
Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failure. (2010) (3)
Dry body weight and ultrafiltration targets in peritoneal dialysis. (2009) (3)
Should Peritoneal Resting be Advised in Ultrafiltration Failure Associated with a Fast Peritoneal Solute Transport Status? (2014) (3)
IgG and complement receptor expression in children treated by peritoneal dialysis (2005) (3)
Soluble VCAM-1 and E-Selectin in PD Patients: The Additive Value of the Free Diffusion Coefficient in the Assessment of Local Peritoneal Production (2015) (3)
Acute interstitial nephritis during continuous intravenous administration of low-dose interleukin-2. (1992) (3)
Grey-Turner's sign in sclerosing peritonitis. (1989) (3)
[Voluntary discontinuation of dialysis treatment by chronic dialysis patients]. (1990) (3)
A hundred patient months' experience with continuous ambulatory peritoneal dialysis. (1982) (2)
Predialytic Period and Baseline Peritoneal Membrane Status: Any Connection? (2010) (2)
Non-invasive assessment of peritoneal membrane alterations (2020) (2)
How good is your serial microdilution technique? (1973) (2)
Nitric oxide-related experiments on peritoneal solute transport in the rabbit. (2001) (2)
Peritoneal dialysis today. (1982) (2)
Renal function influences interleukin-8 background production by cultured human mesothelial cells. (1996) (2)
Or. O.G. Struijk'S Et Al. Reply (1991) (2)
Progress in Peritoneal Dialysis (2011) (2)
The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis (2000) (2)
Oral treatment of CAPD-peritonitis with ciprofloxacin. (1990) (2)
IgG and subclasses in children before and after starting peritoneal dialysis (1997) (2)
Biocompatibility and peritoneal transport. (2009) (2)
Does Alport syndrome affect the basement membrane of peritoneal vessels? (2010) (2)
ENCAPSULATING PERITONEAL SCLEROSIS SO019 T-HELPER CELLS AND FIBROSIS-ASSOCIATED MACROPHAGES DOMINATE THE PERITONEAL INFLAMMATORY INFILTRATE IN EPS PATIENTS (2013) (2)
Peritoneal dialysis in hypothermia, a heart-warming procedure. (1982) (2)
Changing antimicrobial resistance in CAPD peritonitis? (1991) (2)
Prevention of peritonitis: filter or UV system? (1987) (2)
When to Start Dialysis and Whether the First Treatment Should Be Extracorporeal Therapy or Peritoneal Dialysis (2009) (2)
Metabolic disturbances in CAPD patients. (1991) (2)
INFLUENCE OF THE PRECEDING DWELL TIME ON THE PERITONEAL EQUILIBRATION TEST WITH 3.86% GLUCOSE SOLUTION IN AUTOMATED PERITONEAL DIALYSIS (2010) (1)
Peritoneal dialysis - clinical (2013) (1)
Corrigendum: Aging of the Peritoneal Dialysis Membrane (2022) (1)
Celebration of the 50Th Anniversary of the Thesis on Peritoneal Dialysis by Dr. Fred S.T. Boen (2009) (1)
Aging of the Peritoneal Dialysis Membrane (2022) (1)
Impaired Initial Cell Reaction in CAPD-Related Peritonitis (1996) (1)
Mechanisms in ultrafiltration failure of long-term peritoneal dialysis patients (2008) (1)
Biocompatibility of haemodialysis membranes: it matters in acute renal failure. (1995) (1)
Identification of Gene Transcripts Implicated in Peritoneal Membrane Alterations (2016) (1)
Biological markers in peritoneal effluent: are they useful? (2003) (1)
Measurement of Residual Renal Function in Patients Treated with Conti n uous Am bulatory Peritoneal (2005) (1)
Ingestion ofStaphylococcus aureus,Staphylococcus epidermidis, andEscherichia coliby Human Peritoneal Mesothelial Cells (1996) (1)
Assessment of the size selectivity of peritoneal permeability by the restriction coefficient to protein transport (2022) (1)
Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions. (1998) (1)
Peritoneal dialysis: how to improve peritoneal permeability or function. (1997) (1)
Article Commentary: Biocompatibility and Peritoneal Transport (2009) (1)
[A new method of kidney function substitution treatment: continuous ambulatory peritoneal dialysis]. (1980) (1)
A wearable haemodialysis device (2008) (1)
Fluconazole in candida peritonitis in CAPD: an alternative proposal. (1995) (1)
4th annual meeting of the International Society of Blood Purification. November 5-6, 1986, Osaka. (1986) (1)
[The quality of the peritoneum in continuous ambulatory peritoneal dialysis]. (1986) (1)
Peritoneal dialysis - 1 (2014) (1)
PERITONEAL DIALYSIS 2 (2014) (1)
Comprar Nolph and Gokal's Textbook of Peritoneal Dialysis | Khanna, Ramesh | 9780387789392 | Springer (2009) (1)
Opinion: What Are the Problems with Using the Peritoneal Membrane for Long‐Term Dialysis? (2007) (1)
Contents, Vol. 75, 1997 (1997) (0)
The Manchester Contribution to Peritoneal Dialysis (2011) (0)
Assessment of the Peritoneum by Biomarkers in Peritoneal Effluent (2018) (0)
Vitamin Deficiencies in Continuous Ambulatory Peritoneal Dialysis Patients Effects of Supplementation (1990) (0)
Author Index to Abstracts (2002) (0)
Accuracy of erythropoietin determination in dialysate of CAPD patients. (1990) (0)
Acknowledgement to Referees (2008) (0)
SP432SYNDECAN-1 IS EXPRESSED IN INTERENDOTHELIAL JUNCTIONS AND IS NOT ASSOCIATED WITH PERITONEAL SOLUTE TRANSPORT (2016) (0)
FP482ACTIVITY OF B CELL RELATED TRANSCRIPT PROVOKED BY PERITONEAL DIALYSIS TREATMENT IS NOT ACCOMPANIED BY B CELL RELEASE IN PERITONEAL EFFLUENT (2018) (0)
Subject Index Vol. 25, 2007 (2007) (0)
Subject Index Vol. 75, 1997 (1997) (0)
SuO016AFIVE YEAR LONGITUDINAL FOLLOW-UP OF PERITONEAL MEMBRANE TRANSPORT DURING TREATMENT WITH A CONVENTIONAL AND A BIOCOMPATIBLE PD SOLUTION (2018) (0)
No Difference Between Oral and Intraperitoneal Treatment of CAPD Peritonitis with Cephradine (1986) (0)
Case Forum (1994) (0)
[Acquired immunodeficiency in a patient with constrictive pericarditis and exsudative enteropathy]. (1978) (0)
Encapsulating Peritoneal Sclerosis (2013) (0)
Preface (2005) (0)
Contents Vol. 91, 2002 (2002) (0)
Encapsulating peritoneal sclerosis: the state (2011) (0)
Front & Back Matter (2020) (0)
Continuous ambulatory peritoneal dialysis: long-term experience. (1990) (0)
Measurement of Peritoneal Transport (2018) (0)
Residual Renal Function and Peritoneal Dialysis Dose in Adequacy of Peritoneal Dialysis (2018) (0)
SP494TRANSCRIPTOME ALTERATIONS DURING PERITONEAL DIALYSIS TREATMENT (2017) (0)
SP491EFFECTS OF CHRONIC KIDNEY FAILURE AND EXPOSURE TO DIFFERENT DIALYSIS SOLUTIONS ON THE PERITONEAL MEMBRANE (2015) (0)
Author Index/Subject Index Proceedings (2002) (0)
[Liver biopsy in carriers of Australia antigen]. (1972) (0)
Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility (2015) (0)
Fluid and electrolyte balance during peritoneal dialysis (1998) (0)
[Kidney diseases in parenteral drug use]. (1982) (0)
37. Analysis of ultrafiltration failure (UFF) in peritoneal dialysis patients (1997) (0)
[Continuous ambulatory peritoneal dialysis as kidney function replacement; an orientation based on a 3 1/2-year-experience]. (1984) (0)
[Propranolol therapy in hypertension]. (1978) (0)
Massive oedema in a Cape Verde sailor. (2005) (0)
Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratio: A Novel Markers of Inflammation in Chronic Haemodialysis Patients (2014) (0)
Acknowledgement to Reviewers (2010) (0)
Subject Index, Vol. 44, 1986 (1986) (0)
Affect the Basement Membrane of Peritoneal Vessels (2010) (0)
Anatomy and Physiology of the Peritoneum (2018) (0)
Subject Index Vol. 91, 2002 (2002) (0)
Contents Vol. 4, 1986 (1986) (0)
Subject Index, Vol. 4, 1986 (1986) (0)
[The pathophysiology of fluid transport in continuous ambulatory peritoneal dialysis]. (1989) (0)
Front & Back Matter (2020) (0)
MO697: FGF-21 Correlates with Overhydration: Is There a Role for Peritoneal GLUT-1? (2022) (0)
Fabry meets Markov : evaluating biochemistry , disease course and costs in support of health care policy (2013) (0)
SP442LONG-TERM PERITONEAL DIALYSIS TREATMENT IS ACCOMPANIED WITH HIGH EXPRESSION OF B CELL ASSOCIATED GENES (2016) (0)
Cock Schröder, MD PhD, Professor of Pediatrics (2012) (0)
Peritoneal Dialysis Solutions (2018) (0)
Plasma exchange with a membrane filter in glomerulonephritis mediated by antibodies to glomerular basement membrane. (1982) (0)
Contents Vol. 25, 2007 (2007) (0)
In Memory of Fred Boen (1927 – 2017) (2017) (0)
Peritoneal Dialysis Manual: A Guide for Understanding the Treatment (2018) (0)
Peritoneal macrophage beta-2 microglobulin production on bacterial peritonitis in CAPD patients. (1992) (0)
Long-Term Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis (2018) (0)
Biocompatibility of PD fluids (1996) (0)
[Copper uptake during dialysis]. (1972) (0)
The Endothelial Surface Layer after Successful Kidney Transplantation (2016) (0)
Subject Index, Vol. 11, 1993 (1993) (0)
SP479THE ASSOCIATION BETWEEN GLUCOSE EXPOSURE AND THE RISK OF PERITONITIS IN PERITONEAL DIALYSIS PATIENTS (2015) (0)
Isolation, identification, and analysis of 4-acetylaminophenol-glucuronide in body fluids of dialyzed renal patients; a molecular mass marker for peritoneal diffusive transport. (1990) (0)
Measuring peritoneal transport (2009) (0)
Chapterr 6 LISINOPRILL IN A CHRONIC PERITONEAL EXPOSURE MODEL INN THE RAT (2008) (0)
DIALYSIS CARDIOVASCULAR COMPLICATIONS 1 (2014) (0)
Correction of Fluid, Electrolyte, and Acid-Base Derangements by Peritoneal Dialysis in Acute Kidney Injury (2019) (0)
Immune defence mechanisms in the peritoneal cavity of CAPD patients (1999) (0)
Contents, Vol. 11, 1993 (1993) (0)
[An 80-year-old woman with weight loss]. (1982) (0)
Contents, Vol. 44, 1986 (1986) (0)
Peritoneal dialysis: past, present and future (2009) (0)
Dialysate Markers of Peritoneal Tissue during Peritonitis and in Stable Capd (1995) (0)
126 Diurnal blood pressure variation in patients on haemodialysis and on continuous ambulatory peritoneal dialysis (1993) (0)
Chapterr 4 ALPHA-2-MACROGLOBULINN AND ALBUMI N ARE USEFUL SERUM PROTEINSS TO DETECT SUBCLINICAL PERITONITIS IN THE RAT (2008) (0)
UvA-DARE ( Digital Academic Repository ) Various aspects of peritoneal water transport (2007) (0)
[Hepato-cellular jaundice and thrombopenia following prolonged intravenous administration of oil emulsion (Intralipid)]. (1975) (0)
Chapterr 8 PYRUVATE-BUFFEREDD DIALYSATE FLUIDS INDUCE LESS PERITONEALL ANGIOGENESIS AND FIBROSIS THAN CONVENTIONAL SOLUTIONS (2008) (0)
No Relation Between Peritoneal Fibrosis and Free Water Transport in a Rat Model. (2017) (0)
The Endothelial Glycocalyx in the Peritoneal Microcirculation of Rats with Chronic Kidney Failure Exposed to Dialysis Solutions (2016) (0)
Choice of Peritoneal Dialysis Technique (2019) (0)
9 th National Congress of Nephrology, Dialysis, Transplantation and Vascular Access (2013) (0)
Markers of Peritoneal Membrane Status (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Raymondd T. Krediet?

Raymondd T. Krediet is affiliated with the following schools:

Raymondd T. Krediet's Academic­Influence.com Rankings